vs
Cytek Biosciences, Inc.（CTKB）与MID PENN BANCORP INC（MPB）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是MID PENN BANCORP INC的1.0倍（$62.1M vs $62.0M），MID PENN BANCORP INC净利率更高（31.4% vs -70.9%，领先102.3%），MID PENN BANCORP INC同比增速更快（30.8% vs 8.1%），MID PENN BANCORP INC自由现金流更多（$71.8M vs $-1.8M），过去两年MID PENN BANCORP INC的营收复合增速更高（21.1% vs 17.7%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
该资料实际介绍的是1973年成立于新泽西州切里希尔的商业银行，该银行在2007年被多伦多道明银行收购，并入其旗下的TD Banknorth，之后TD Banknorth统一更名为TD银行。
CTKB vs MPB — 直观对比
营收规模更大
CTKB
是对方的1.0倍
$62.0M
营收增速更快
MPB
高出22.7%
8.1%
净利率更高
MPB
高出102.3%
-70.9%
自由现金流更多
MPB
多$73.6M
$-1.8M
两年增速更快
MPB
近两年复合增速
17.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $62.0M |
| 净利润 | $-44.1M | $19.4M |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | 43.6% |
| 净利率 | -70.9% | 31.4% |
| 营收同比 | 8.1% | 30.8% |
| 净利润同比 | -557.1% | 47.0% |
| 每股收益（稀释后） | — | $0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBMPB
| Q4 25 | $62.1M | $62.0M | ||
| Q3 25 | $52.3M | $61.8M | ||
| Q2 25 | $45.6M | $54.3M | ||
| Q1 25 | $41.5M | $47.7M | ||
| Q4 24 | $57.5M | $47.4M | ||
| Q3 24 | $51.5M | $45.3M | ||
| Q2 24 | $46.6M | $44.1M | ||
| Q1 24 | $44.9M | $42.3M |
净利润CTKBMPB
| Q4 25 | $-44.1M | $19.4M | ||
| Q3 25 | $-5.5M | $18.3M | ||
| Q2 25 | $-5.6M | $4.8M | ||
| Q1 25 | $-11.4M | $13.7M | ||
| Q4 24 | $9.6M | $13.2M | ||
| Q3 24 | $941.0K | $12.3M | ||
| Q2 24 | $-10.4M | $11.8M | ||
| Q1 24 | $-6.2M | $12.1M |
毛利率CTKBMPB
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
营业利润率CTKBMPB
| Q4 25 | -9.0% | 43.6% | ||
| Q3 25 | -17.6% | 39.3% | ||
| Q2 25 | -23.3% | 7.9% | ||
| Q1 25 | -36.1% | 35.2% | ||
| Q4 24 | 5.2% | 34.1% | ||
| Q3 24 | -8.2% | 32.8% | ||
| Q2 24 | -18.3% | 32.4% | ||
| Q1 24 | -23.9% | 34.8% |
净利率CTKBMPB
| Q4 25 | -70.9% | 31.4% | ||
| Q3 25 | -10.5% | 29.6% | ||
| Q2 25 | -12.2% | 8.8% | ||
| Q1 25 | -27.5% | 28.8% | ||
| Q4 24 | 16.8% | 27.9% | ||
| Q3 24 | 1.8% | 27.1% | ||
| Q2 24 | -22.4% | 26.7% | ||
| Q1 24 | -13.8% | 28.7% |
每股收益（稀释后）CTKBMPB
| Q4 25 | — | $0.83 | ||
| Q3 25 | — | $0.79 | ||
| Q2 25 | — | $0.22 | ||
| Q1 25 | — | $0.71 | ||
| Q4 24 | — | $0.72 | ||
| Q3 24 | — | $0.74 | ||
| Q2 24 | — | $0.71 | ||
| Q1 24 | — | $0.73 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $341.7M | $814.1M |
| 总资产 | $461.5M | $6.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTKBMPB
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — | ||
| Q1 24 | $168.8M | — |
股东权益CTKBMPB
| Q4 25 | $341.7M | $814.1M | ||
| Q3 25 | $378.6M | $796.3M | ||
| Q2 25 | $377.6M | $775.7M | ||
| Q1 25 | $379.6M | $667.9M | ||
| Q4 24 | $395.7M | $655.0M | ||
| Q3 24 | $385.5M | $573.1M | ||
| Q2 24 | $389.1M | $559.7M | ||
| Q1 24 | $392.6M | $551.0M |
总资产CTKBMPB
| Q4 25 | $461.5M | $6.1B | ||
| Q3 25 | $494.9M | $6.3B | ||
| Q2 25 | $493.3M | $6.4B | ||
| Q1 25 | $482.6M | $5.5B | ||
| Q4 24 | $499.5M | $5.5B | ||
| Q3 24 | $491.2M | $5.5B | ||
| Q2 24 | $483.7M | $5.4B | ||
| Q1 24 | $492.1M | $5.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $80.0M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $71.8M |
| 自由现金流率自由现金流/营收 | -2.9% | 115.8% |
| 资本支出强度资本支出/营收 | 1.6% | 13.3% |
| 现金转化率经营现金流/净利润 | — | 4.12× |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $132.1M |
8季度趋势，按日历期对齐
经营现金流CTKBMPB
| Q4 25 | $-771.0K | $80.0M | ||
| Q3 25 | $-3.9M | $26.3M | ||
| Q2 25 | $108.0K | $29.0M | ||
| Q1 25 | $-125.0K | $11.5M | ||
| Q4 24 | $2.0M | $51.4M | ||
| Q3 24 | $13.2M | $16.9M | ||
| Q2 24 | $6.2M | $18.0M | ||
| Q1 24 | $4.0M | $12.4M |
自由现金流CTKBMPB
| Q4 25 | $-1.8M | $71.8M | ||
| Q3 25 | $-4.6M | $24.3M | ||
| Q2 25 | $-1.5M | $27.2M | ||
| Q1 25 | $-974.0K | $8.8M | ||
| Q4 24 | $1.1M | $44.5M | ||
| Q3 24 | $12.2M | $16.8M | ||
| Q2 24 | $5.2M | $17.7M | ||
| Q1 24 | $3.4M | $12.1M |
自由现金流率CTKBMPB
| Q4 25 | -2.9% | 115.8% | ||
| Q3 25 | -8.7% | 39.4% | ||
| Q2 25 | -3.2% | 50.1% | ||
| Q1 25 | -2.3% | 18.4% | ||
| Q4 24 | 1.9% | 93.8% | ||
| Q3 24 | 23.7% | 37.1% | ||
| Q2 24 | 11.0% | 40.2% | ||
| Q1 24 | 7.6% | 28.5% |
资本支出强度CTKBMPB
| Q4 25 | 1.6% | 13.3% | ||
| Q3 25 | 1.3% | 3.1% | ||
| Q2 25 | 3.5% | 3.2% | ||
| Q1 25 | 2.0% | 5.7% | ||
| Q4 24 | 1.6% | 14.6% | ||
| Q3 24 | 2.0% | 0.0% | ||
| Q2 24 | 2.3% | 0.7% | ||
| Q1 24 | 1.3% | 0.8% |
现金转化率CTKBMPB
| Q4 25 | — | 4.12× | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 6.08× | ||
| Q1 25 | — | 0.84× | ||
| Q4 24 | 0.21× | 3.88× | ||
| Q3 24 | 14.05× | 1.37× | ||
| Q2 24 | — | 1.53× | ||
| Q1 24 | — | 1.02× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
MPB
暂无分部数据
